NCT00896311View on ClinicalTrials.gov

Intravenous (IV) Nitroglycerin for Versions in Nulliparous Women

NACompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

October 31, 2006

Study Completion Date

February 29, 2008

Conditions
Breech PresentationComplication of Pregnancy
Interventions
DRUG

IV Nitroglycerin

IV injection, initial dose of 1ml, with further doses of 1-3mL, up to a recommended maximum of 10mL

DRUG

Normal saline

IV injection, initial dose of 1ml, with further doses of 1-3mL, up to a recommended maximum of 10mL

Trial Locations (3)

T2N 4J8

Foothills Medical Centre, Calgary

Unknown

Peter Lougheed Centre, Calgary

Rockyview Hospital, Calgary

All Listed Sponsors
lead

University of Calgary

OTHER

NCT00896311 - Intravenous (IV) Nitroglycerin for Versions in Nulliparous Women | Biotech Hunter | Biotech Hunter